India vs South-East Asia (WHO region): Cases started on MDR-TB treatment
India
51,765
in 2024
South-East Asia (WHO region)
57,653
in 2024
India rank
1st
South-East Asia (WHO region) rank
3rd
Cases started on MDR-TB treatment over time
- India
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 57,653 against 51,765 in India, a difference of 5,888.
That makes South-East Asia (WHO region)'s figure about 1.1 times India's.
Across all 17 years both countries report, South-East Asia (WHO region) has been ahead every year.
India ranks 1st and South-East Asia (WHO region) ranks 3rd of 193 countries.
South-East Asia (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 663 | 1,371 | 708 | South-East Asia (WHO region) |
| 2010s | 26,882 | 30,839 | 3,957 | South-East Asia (WHO region) |
| 2020s | 53,302 | 59,055 | 5,753 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, India or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 57,653 against 51,765 in India as of 2024.
- What is the difference in cases started on mdr-tb treatment between India and South-East Asia (WHO region)?
- 5,888, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for India and South-East Asia (WHO region)?
- 17 years are reported by both, from 2008 to 2024.
- How do India and South-East Asia (WHO region) rank globally for cases started on mdr-tb treatment?
- India ranks 1st and South-East Asia (WHO region) ranks 3rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.